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Core tip: This is a comprehensive review regarding 
the role and mechanism of the CD38/Cyclic adenosine 
diphosphate ribose (cADPR)/Ca2+ signaling pathway in 
various cellular processes. We introduce the structure 
and function of cADPR, together with its production 
and degradation pathways. We also describe CD38, 
the main enzyme that is responsible for synthesis of 
cADPR, through its structure and topology. Finally, we 
summarize the functions of the CD38/cADPR/Ca2+ sig-
naling pathway under both physiological and pathologi-
cal conditions.
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INTRODUCTION
Discovered more than two decades ago, cyclic adenosine 
diphosphate ribose (cADPR) has been established as a 
second messenger, according to criteria first proposed 
by Sutherland and co-workers[1]. Together with inositol 
1,4,5-trisphosphate (IP3) and nicotinic acid adenine dinu-
cleotide phosphate (NAADP), cADPR has been recog-
nized as a principal second messenger involved in cellular 
Ca2+ mobilization. Extracellular stimuli can induce cAD-
PR production, which leads to Ca2+ mobilization from 
intracellular stores as well as Ca2+ entry from the extracel-
lular compartment to initiate diverse cellular responses. 
cADPR is synthesized by ADP-ribosyl cyclases and the 
major ADP-ribosyl cyclase in mammals is CD38 (Figure 
1). In this review, we will first introduce the structure and 
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Abstract
Mobilization of intracellular Ca2+ stores is involved in 
many diverse cell functions, including: cell proliferation; 
differentiation; fertilization; muscle contraction; secre-
tion of neurotransmitters, hormones and enzymes; 
and lymphocyte activation and proliferation. Cyclic ad-
enosine diphosphate ribose (cADPR) is an endogenous 
Ca2+ mobilizing nucleotide present in many cell types 
and species, from plants to animals. cADPR is formed 
by ADP-ribosyl cyclases from nicotinamide adenine di-
nucleotide. The main ADP-ribosyl cyclase in mammals 
is CD38, a multi-functional enzyme and a type Ⅱ mem-
brane protein. It has been shown that many extracel-
lular stimuli can induce cADPR production that leads 
to calcium release or influx, establishing cADPR as a 
second messenger. cADPR has been linked to a wide 
variety of cellular processes, but the molecular mecha-
nisms regarding cADPR signaling remain elusive. The 
aim of this review is to summarize the CD38/cADPR/
Ca2+ signaling pathway, focusing on the recent advanc-
es involving the mechanism and physiological functions 
of cADPR-mediated Ca2+ mobilization.
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function of  cADPR. Next, the structure and topology of  
CD38 will be reviewed. Finally, the physiological func-
tions of  CD38/cADPR/Ca2+ signaling and their involve-
ment in pathological processes will be summarized.
THE STRUCTURE AND FUNCTION OF 
CADPR 
A suitable model system is the foundation of  any novel 
finding and this concept is also true for the discovery of  
cADPR. Sea urchin eggs are large and amenable for mi-
croinjection studies so that Ca2+ mobilizing activities dur-
ing fertilization can be readily observed, and it is easy to 
isolate endoplasmic reticulum (ER) from sea urchin eggs, 
making them the perfect system to investigate mecha-
nisms of  intracellular Ca2+ mobilization[2]. Taking ad-
vantage of  the sea urchin homogenate preparation and 
use of  the fluorescent Ca2+ indicator Fura 2, Lee et al[3] 
and Clapper et al[4] found that the pyridine nucleotide 
nicotinamide adenine dinucleotide (NAD) can invoke a 
delayed Ca2+ release from ER independent of  IP3. They 
then determined that this delay was due to enzymatic 
conversion of  NAD to cADPR by the homogenate. 
Later, Lee et al[5] solved the structure of  cADPR by x-ray 
crystallography and showed that it is a novel cyclic nucle-
otide formed by the covalent linkage of  the N1 nitrogen 
of  the adenine ring to the anomeric carbon of  the termi-
nal ribose to become a closed cyclic structure (Figure 2). 
Benefiting from the identified structure, multiple cADPR 
analogs have been synthesized, which greatly promoted 
research on the role and mechanism of  cADPR-mediated 
Ca2+ signaling[6-9]. 
From the very beginning of  research on cADPR, sev-
eral pharmacological studies have clearly shown that the 
mechanism of  cADPR-induced Ca2+ release is different 
from that of  IP3. For example, desensitization experi-
ments demonstrated that the sea urchin homogenates 
which were desensitized to IP3 would still respond to 
cADPR[4], and the IP3 inhibitor heparin had no effect on 
the cADPR-induced Ca2+ release[10]. Using the sea urchin 
homogenate as the model, Galione et al[11] proposed that 
calcium-induced calcium release (CICR) may be modu-
lated by cADPR, since concentrations of  cADPR in the 
nanomolar range could greatly increase the sensitivity to 
Ca2+ during the CICR process. Thus, ryanodine recep-
tors (RyRs) were proposed to be the cADPR receptors 
through which the CICR functions, and this idea was 
supported by several subsequent studies. For example, 
cADPR was shown to directly activate RyR2 that was 
incorporated into lipid bilayers[12]. In HEK293 cells trans-
fected with an islet type RyR, which is a splice variant 
of  the RyR2 gene by alternative splicing of  exons 4 and 
75, Ca2+ release was enhanced in the presence of  100 
μmol/L cADPR, and the effect could be reversed by pre-
incubating with a cADPR antagonist, 8-bromo-cADPR 
(8-Br-cADPR)[13]. Similarly, cADPR triggered a marked 
Ca2+ transient in HEK293 cells that stably expressed 
RyR1 and RyR3, and this Ca2+ transient was abolished by 
dantrolene, an RyR antagonist[14]. In summary, all these 
results suggested that RyRs might serve as cADPR recep-
tors (Figure 1). 
However, further experiments argued that the action 
of  cADPR on ryanodine receptors might require the 
assistance of  additional protein factors (Figure 1). For 
example, both calmodulin and FK506 binding protein 
(FKBP) have been shown to be required for cADPR 
action[15-20]. These data suggested that cADPR does not 
directly bind to the ryanodine receptors, but acts through 
some intermediate proteins, whose definitive identities 
remain to be established. Zheng et al[21] demonstrated in 
mouse bladder smooth muscle that Ca2+ release induced 
by cADPR is actually mediated by FKBP12.6 proteins. 
Nevertheless, additional research such as genome-wide 
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Figure 1  Cyclic adenosine diphosphate ribose mediated Ca2+ signaling. TRPM2: Transient receptor potential cation channel M2; cADPR: Cyclic adenosine di-
phosphate ribose; NAADP: Nicotinic acid adenine dinucleotide phosphate; NAD: Nicotinamide adenine dinucleotide; ER: Endoplasmic reticulum.
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In addition, growing evidence has shown that cADPR 
also evokes Ca2+ influx (Figure 1)[22]. It has been shown 
that cADPR can significantly potentiate the transient re-
ceptor potential cation channel M2 (TRPM2) channel ac-
tivity in a temperature dependent manner[23]. Similarly, we 
recently synthesized a novel fluorescent caged cADPR 
analogue, coumarin caged isopropylidene-protected cI-
DPRE (Co-i-cIDPRE), and found that it is a potent and 
controllable cell permeant cADPR agonist. Moreover, we 
demonstrated that uncaging of  Co-i-cIDPRE activates 
RyRs for Ca2+ mobilization and triggers Ca2+ influx via 
TRPM2[24]. Yet, another experiment showed that TRPM2 
is not involved in the effect of  another membrane-per-
meant cADPR agonist, 8-bromo-cyclic IDP-ribose (8-Br-
N1-cIDPR), which induced Ca2+ entry in T cells[25]. Thus, 
the channel that mediates the cADPR induced Ca2+ influx 
still needs to be elucidated.
ENZYMATIC PATHWAY OF CADPR 
SYNTHESIS AND DEGRADATION
As mentioned above, the effect of  NAD to induce Ca2+ 
release in sea urchin eggs was shown to result from its 
enzymatic conversion to cADPR. Subsequently, a similar 
enzymatic activity was shown to exist in a wide variety of  
mammalian tissues[26]. The first purified enzyme shown 
to produce cADPR from NAD was identified in Aplysia 
and was later named ADP-ribosyl cyclase[27]. Surpris-
ingly, the amino acid sequence of  Aplysia ADP-ribosyl 
cyclase, a soluble 30 kDa protein, showed overall about 
68% homology with human CD38, a lymphocyte anti-
gen[28,29]. CD38 was indeed able to catalyze the cyclization 
of  NAD to cADPR in pancreatic beta-cells[30]. More-
over, purified murine CD38 was able to convert NAD 
to cADPR in an in vitro assay[28]. Later, CD157, a GPI-
anchored antigen that shared 30% homology with CD38, 
was found to have ADP-ribosyl cyclase activity as well[31].
Overall, these ADP-ribosyl cyclases share about 
25%-30% sequence identity[32], and this family is likely 
to grow since researchers have continued to find ADP-
ribosyl cyclase activity that is undefined. In addition, it 
appears that these unknown cyclases function differently 
in different tissues. For example, an unidentified cardiac 
ADPR cyclase can be inhibited by micromolar concentra-
tions of  Zn2+, which is different from the effects of  this 
cation on CD38 and CD157[33,34]. A similar ADP-ribosyl 
cyclase that can be inhibited by the divalent cations Zn2+ 
and Cu2+ has also been found in the disks of  bovine reti-
nal rod outer segments[35]. Specific inhibitor based analy-
sis confirmed the existence of  a distinct ADP-ribosyl 
cyclase in the kidney since it responded differently to the 
inhibitor 4,4’-dihydroxy azobenzene (DHAB) treatment 
than CD38[36].
So far, CD38 is still considered to be the main mam-
malian ADP-ribosyl cyclase, as shown by the fact that 
extracts of  tissues from CD38 knockout mice have little 
if  any ADP-ribosyl activity compared to those from wild 
type mice. When incubated with NAD in vitro, CD38 only 
produced a small portion of  cADPR, while the major-
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Figure 2  Schematic of the structure and synthesis of cyclic adenosine diphosphate ribose. cADPR: Cyclic adenosine diphosphate ribose; NAADP: Nicotinic 
acid adenine dinucleotide phosphate; NAD: Nicotinamide adenine dinucleotide.
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ity of  the product is ADP-ribose; thus CD38 possesses 
both cyclase and NADase activities. In addition, CD38 
can hydrolyze cADPR to ADP-ribose and, other than 
CD157, it remains the only ADP-ribosyl cyclase that has 
been identified in mammals[28]. Moreover, CD38 shows 
another bifunctional character in that it catalyzes the syn-
thesis and hydrolysis of  another secondary messenger, 
NAADP. In this reaction, CD38 catalyzes the exchange 
of  the nicotinamide group of  NADP with nicotinic 
acid under acidic conditions to generate NAADP; fur-
thermore, NAADP can also be hydrolyzed by CD38 to 
ADPRP (Figure 2)[37,38]. Understanding the structure and 
function of  CD38 is a crucial part of  cADPR/Ca2+ sig-
naling research.
STRUCTURE AND ENZYMATIC 
FUNCTION OF CD38
CD38 is a transmembrane protein, containing a short 
21 amino acid residue N-terminal cytoplasmic tail, a 23 
amino acid residue hydrophobic transmembrane domain, 
and a large 256 amino acid residue carboxyl-terminal ex-
tracellular domain with four putative glycosylation sites[39]. 
The extracellular domain of  human CD38 with the gly-
cosylation sites removed has been expressed in yeast and 
purified. Structural analysis of  the recombinant CD38 by 
X-ray crystallography showed that the secondary struc-
ture of  CD38 is similar to that of  the Aplysia cyclase. 
Overall, both CD38 and the cyclase have similar topology 
although the cyclase forms dimers in the crystals whereas 
CD38 does not. The middle cleft of  both proteins forms 
a deep pocket as the active site, with a TLEDTL con-
served sequence sitting in the bottom of  the pocket[40,41]. 
Site-directed mutagenesis studies identified Glu226 as the 
catalytic residue of  CD38[42]. Two other residues, Glu146 
and Thr221, were found to be essential for the cyclization 
and hydrolysis activity of  CD38, respectively[43]. Upon 
binding of  NAD to the active site, the nicotinamide ring 
interacts with Trp189 by hydrophobic ring stacking, the 2’ 
and 3’ hydroxyls of  the northern ribose form hydrogen 
bonds with Glu226, and the ribose diphosphate moi-
ety interacts with amino acids Trp125, Ser126, Arg127, 
Thr221 and Phe222. Upon cleavage of  the nicotinamide 
ring, the N1 nitrogen of  the adenine ring gains access to 
the anomeric carbon to form a covalent bond and pro-
duce cADPR. Alternatively, a water molecule, rather than 
the adenine ring, attacks the intermediate to form ADP-
ribose[44]. In contrast to the formation of  cyclic ADP-
ribose from NAD, CD38 also catalyzes the formation of  
NAADP from NADP. Under acidic pH and in the pres-
ence of  nicotinic acid, the acidic residues in the active site 
of  CD38 are protonated, thereby facilitating the nucleo-
philic attack of  the intermediate of  NADP by nicotinic 
acid to generate NAADP[44]. 
TOPOLOGY OF CD38
Structurally, CD38 is predicted to be a type-II transmem-
brane protein with its catalytic C-terminal domain located 
outside of  the cell[39]. This circumstance presents a dilem-
ma because the NAD substrate is located intracellularly 
whereas the enzyme is positioned extracellularly. If  so, 
cytosolic NAD must be transported out of  cells first and 
then cyclized by CD38 to produce cADPR in the extra-
cellular space. Subsequently, the cADPR product must be 
transported back into the cytosol to induce Ca2+ release 
from the ER. This scenario obviously presents a “topo-
logical paradox” for the cADPR/Ca2+ signaling cascade. 
Two general hypotheses have been proposed to solve this 
puzzle (Figure 3). The first proposal is based on the pres-
ence of  transporters, such as connexin 43 hemichannels, 
which allow intracellular NAD to move to the extracel-
lular space so that it is available for access to the catalytic 
domain of  CD38 to be converted to cADPR[45]. The 
cADPR product is then transferred back to cells via either 
CD38 or nucleoside transporters[46]. Besides this direct 
transport model via transporters, Zocchi et al[47] also sug-
gested that CD38 undergoes an extensive internalization 
through invaginations of  the plasma membrane to form 
endocytotic vesicles, which makes the active site of  CD38 
intravesicular and able to convert cytosolic NAD into 
cADPR. CD38 itself  is a unidirectional transmembrane 
transporter of  cADPR that mediates the cADPR efflux 
into the cytoplasm to reach the Ca2+ store, while influx of  
the cytosolic NAD+ substrate into the endocytotic CD38-
containing vesicles is mediated by other transmembrane 
transporters, such as connexin 43 hemichannels[48]. The 
internalization of  CD38 has been supported by several 
studies. For example, the internalization of  CD38 can 
be induced by NADP in Chinese hamster ovary (CHO) 
cells[49] and hemin treatment can induce internalization of  
CD38 in K562 cells[50]. Rah et al[51] have also demonstrat-
ed that association of  phospho-nonmuscle myosin heavy 
chain ⅡA with tyrosine kinase Lck and CD38 is critical 
for the internalization and activation of  CD38. However, 
mechanisms regarding the transporter mediated CD38 
activation process remain elusive. For example, connexin 
43 hemichannels are opened for NAD export only when 
the cellular Ca2+ is 100 nmol/L; thus this system is unlike-
ly to operate when Ca2+ is elevated above basal levels[45].
The second proposal offered to explain the topologi-
cal paradox involves a consideration of  the orientation of  
CD38. Bruzzone and coworkers have shown that treat-
ment of  granulocytes with 8-Br-cyclic adenosine mono-
phosphate (cAMP), a cell-permeant analog of  cAMP, in-
duced serine phosphorylation of  CD38, correlating with 
a cAMP-dependent intracellular cADPR synthesis[52]. Al-
though the exact location of  the phosphorylation sites is 
unknown, it was predicted to be in the catalytic C-terminal 
domain that contains multiple serine residues. However, 
if  the catalytic domain of  CD38 is phosphorylated by 
protein kinase A (PKA), this domain should be in the cy-
tosol to directly cyclize NAD, thereby synthesizing cAD-
PR intracellularly. This suggests that although CD38 is 
believed to be a type-Ⅱ protein, at least a portion of  the 
total CD38 is expressed as a type-Ⅲ membrane protein 
with its C-terminal catalytic domain sitting in the cyto-
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sol[53]. Since the number of  positive charges that determine 
the polarity of  membrane protein is equal on each side of  
the CD38 transmembrane segment, studies from protease 
digestion[54] and electron microscopy[55] showed that the 
nuclear CD38 might be a type-Ⅲ membrane protein. Most 
recently, Zhao et al[56] reported that expression of  a cyto-
solic CD38 protein with deletion of  both the N-terminal 
tail and transmembrane domain results in intact disulfides 
as well as active enzyme in spite of  the cytosolic reductive 
environment; this result appears to solve the fundamental 
need of  the six disulfides for CD38 enzymatic activity. 
Based on this finding, they consequently proved the co-
expression of  type Ⅱ and type Ⅲ CD38 on the surface 
of  leukemia HL-60 cells during retinoic acid-induced dif-
ferentiation and on interferon Υ-activated natural human 
monocytes and U937 cells[57]. They proposed that the type-
Ⅲ structure may take part in fast cellular responses, while 
the type-Ⅱstructure may be more suitable for slower and 
long term responses (Figure 3)[58]. 
PHYSIOLOGICAL FUNCTIONS OF THE 
CD38/CADPR/CA2+ PATHWAY
In addition to its role in cADPR production, another 
function of  CD38 is to regulate the NAD level inside 
cells. It has been well established that NAD plays an 
essential role in energy metabolism and is involved in 
diverse signal transduction pathways. A rather surprising 
finding is that CD38 has a dramatic role in intracellular 
NAD metabolism. NAD levels in CD38 knockout mice 
are 10 to 20-fold higher than that in wild-type animals. 
These results suggest that CD38 is a major regulator of  
NAD levels in mammalian cells[59].
CD38 was originally identified as a lymphocyte anti-
gen; thus it is not surprising that the CD38/cADPR/Ca2+ 
pathway plays an important role in inflammatory process-
es. In an ischemic stroke study, CD38-/- mice produced 
less monocyte chemoattractant protein-1 (MCP-1) after 
temporary middle cerebral artery occlusion and had fewer 
infiltrating macrophages and lymphocytes in the ischemic 
hemisphere than the wild type mice, whereas the amount 
of  resident microglia was unaltered. The same study also 
demonstrated that CD38 affected immune cell migration 
as well as activation, two crucial postischemic inflamma-
tory responses in secondary brain damage, suggesting 
that CD38 might be a therapeutic target to modulate 
the inflammatory mechanisms after cerebral ischemia[60]. 
Recently, Ng et al[61] used intravital multi-photon micros-
copy to observe the neutrophil granulocyte traffic into 
the injury site in the dermis of  mice and found that the 
amplification phase, which is the attraction of  more neu-
trophils toward the damage focus after the initial phase 
of  migration by scouting neutrophils, was mediated by 
cADPR. cADPR and CD38 were also involved in the 
regulation of  leukocyte adhesion and chemotaxis and 
were required for the deletion of  T regulatory cells dur-
ing inflammation as well[62]. In addition, 8-Br-cADPR, a 
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Figure 3  Models of CD38 topology. cADPR: Cyclic adenosine diphosphate ribose; NAD: Nicotinamide adenine dinucleotide; RyR: Ryanodine receptor.
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cADPR antagonist, inhibited the MCP-1 induced Ca2+ 
increase, reactive oxygen species (ROS) production and 
apoptosis in human retinal pigment epithelium, suggest-
ing that cADPR is also involved in the inflammatory re-
sponses of  age-related macular degeneration (AMD)[63].
Recently, we demonstrated that cADPR is important 
for regulating cell proliferation and neuronal differentia-
tion in PC12 cells. We found that acetylcholine (Ach) 
activates the CD38/cADPR pathway to induce Ca2+ 
release and the CD38/cADPR/Ca2+ signaling pathway 
is required for Ach-stimulated cell proliferation in PC12 
cells. Interestingly, inhibition of  the cADPR pathway ac-
celerated nerve growth factor (NGF)-induced neuronal 
differentiation in PC12 cells. On the other hand, CD38 
overexpression increased cell proliferation but delayed 
NGF-induced differentiation. Taken together, we demon-
strated that cADPR plays a dichotomic role in regulating 
proliferation and neuronal differentiation of  PC12 cells[64].
Abscisic acid (ABA) is an endogenous stimulator of  
insulin secretion in human and murine pancreatic beta 
cells. ABA triggered activation of  CD38 and production 
of  cADPR before insulin release, suggesting that CD38 
is a regulator of  insulin release[65]. Also, CD38 expression 
and cADPR production induced by ABA were required 
for ABA-induced upregulation of  COX-2 and prosta-
glandin E2 in human mesenchymal stem cells (MSC) and 
for chemokinesis of  MSC[66].
Since cADPR can activate RyRs for Ca2+ release from 
ER and can modulate the CICR process, the CD38/
cADPR/Ca2+ pathway is predicted to participate in the 
regulation of  cardiac activities, including cardiogenesis 
and the function of  adult cardiac tissue. In fact, ever 
since the discovery of  cADPR, researchers have vigor-
ously explored its role in cardiac tissues. Galione et al[67] 
showed that application of  cADPR through a patch 
electrode resulted in an increase in Ca2+ transients with 
a concomitant increase of  the magnitude of  contraction 
in guinea-pig cardiac ventricular myocytes, whereas ap-
plication of  the inhibitor 8-amino-cADPR resulted in 
a significant reduction in contractions and Ca2+ release 
from the SR. Similarly, in rat cardiac ventricular myocytes, 
cADPR increased the frequency of  Ca2+ “sparks”, which 
may contribute to the increase in subsequent whole-
cell Ca2+ transients[68]. In addition, Prakash et al[69] found 
that microinjection of  cADPR into adult rat ventricular 
myocytes not only induced sustained Ca2+ responses in a 
concentration dependent manner but also increased the 
frequency and amplitude of  spontaneous Ca2+ waves, 
which were completely blocked by 8-amino-cADPR, a 
cADPR antagonist.
Interestingly, cardiac hypertrophy developed only in 
CD38 knockout male mice. The expression of  RyR pro-
tein was increased only in female CD38 knockout mice 
compared with wild type, suggesting that the CD38/
cADPR signaling plays an important role in intracellular 
Ca2+ homeostasis in cardiac myocytes in vivo, although its 
deficiency was compensated differentially according to 
gender[70].
cADPR was also shown to be involved in angiotensin 
Ⅱ-induced cardiac hypertrophy[71]. In rat cardiomyocytes, 
angiotensin Ⅱ evoked a Ca2+ increase via IP3R to activate 
PKC, which then activated the NAD(P)H oxidase to ini-
tiate ROS generation. The ROS together with Ca2+ then 
activated the ADP-ribose cyclase to synthesize cADPR, 
which induced a sustained increase of  both Ca2+ and 
ROS and finally led to cardiac hypertrophy[72]. Most re-
cently, Xu et al[73] demonstrated that CD38/cADPR was 
involved in the regulation of  superoxide (O2•-) production 
in mouse coronary arterial myocytes (CAMs). NAD(P)H 
oxidase is responsible for O2•- production. Since CD38 
can use NAD, an NAD(P)H oxidase product, to produce 
cADPR and cADPR production can result in an increase 
in NAD(P)H oxidase activity, the system contains a posi-
tive feedback loop. Xu et al[73] found that oxotremorine, a 
muscarinic type 1 receptor agonist, stimulated intracellu-
lar O2•- production in CAMs that was inhibited in CD38 
knockout, CD38 knockdown, or nicotinamide-treated 
(a CD38 inhibitor) cells. On the other hand, direct ap-
plication of  cADPR into CAMs increased intracellular 
Ca2+ and O2•- production in CD38-/- CAMs. Moreover, 
CD38 knockout, Nox1 knockdown or Nox4 knockdown 
blocked oxotremorine-induced contraction in the iso-
lated perfused coronary arteries in mice. Taken together, 
these data indicate that the CD38/cADPR pathway is an 
important regulator of  Nox-mediated intracellular O2•- 
production.
The CD38/cADPR/Ca2+ pathway has also been 
shown to regulate the cardiogenesis process. We recently 
studied the role of  CD38/cADPR/Ca2+ in the cardio-
myogenesis of  mouse embryonic stem (ES) cells. We 
found that beating cells appeared earlier and were more 
abundant in CD38 knockdown embryoid bodies (EBs) 
than control EBs, and the expression of  several cardiac 
markers was increased significantly in CD38 knockdown 
EBs than control EBs. Similarly, more cardiomyocytes 
(CMs) existed in CD38 knockdown or cADPR antago-
nist-treated EBs compared to control EBs. Conversely, 
CD38 overexpression in mouse ES cells markedly inhib-
ited CM differentiation. Surprisingly, CD38 knockdown 
ES cell derived CMs possess the functional properties 
characteristic of  normal ES cell derived CMs. In addition, 
we found that the CD38/cADPR pathway inhibited the 
Erk1/2 cascade during CM differentiation of  ES cells, 
and transient inhibition of  Erk1/2 blocked the enhancive 
effects of  CD38 knockdown on the differentiation of  
CM from ES cells. Taken together, we demonstrated that 
the CD38/cADPR/Ca2+ signaling pathway inhibits the 
CM differentiation of  mouse ES cells[74]. 
The mechanism underlying cADPR regulation of  Ca2+ 
sparks in cardiomyocyte remains elusive. Zhang et al[19]. 
showed that cADPR markedly increased the Ca2+ spark 
frequency in cardiomyocytes isolated from wild type 
mice, whereas cADPR failed to initiate Ca2+ sparks in car-
diomyocytes isolated from FK506 binding protein 12.6 
(FKBP12.6) knockout mice. They further demonstrated 
that cADPR induced FKBP12.6 dissociation from RyRs 
in a phosphorylation-dependent manner. Yet, another 
study showed that cAMP signaling is required for the 
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role of  cADPR in the beta-adrenergic receptor induced 
Ca2+increase in rat cardiomyocytes. They found that the 
isoproterenol-mediated increase of  Ca2+ was blocked by 
pretreatment with 8-Br-cADPR, PKA inhibitor H89 or 
a high concentration of  ryanodine. Moreover, incuba-
tion of  ventricular lysates with isoproterenol, forskolin 
or cAMP resulted in activation of  ADP-ribosyl cyclase 
of  the ventricular lysates[34]. Interestingly, for comparison, 
estrogen increased CD38 expression and its cyclase activ-
ity, but did not affect its hydrolase activity, while proges-
terone eliminated the effects of  estrogen on CD38 in the 
rat myometrium[75]. Nevertheless, the mechanism of  how 
the CD38/cADPR is involved in the regulation of  car-
diac function is still unclear.
CD38/CADPR/CA2+ PATHWAY IN 
PATHOLOGICAL PROCESSES
The CD38/cADPR/Ca2+ pathway has been suggested 
to be involved in various pathological processes. For 
example, CD38 deficiency accelerated diabetes in a non-
obese diabetic (NOD) mice model[76]. It has also been 
shown that both the specific kidney ADP-ribosyl cyclase 
activity and cADPR production were increased in the 
kidneys of  diabetic mice, suggesting that cADPR plays 
a role in the renal pathogenesis of  diabetes[77]. Down-
regulation of  CD38 has also been shown to mediate the 
intermittent hypoxia induced impairment of  glucose-
induced insulin secretion, suggesting that CD38 plays a 
role in type 2 diabetes progression[78]. Numerous studies 
have been attempted to dissect the molecular mechanism 
of  the role of  CD38/cADPR/Ca2+ pathway in mediat-
ing diabetes in order to identify an alternative therapeutic 
tool. Tian et al[79] found that the content of  cADPR was 
elevated with concomitant enhanced activity of  RyR2 in 
ventricular myocytes isolated from a type 1 diabetic rat 
model, suggesting that cADPR mediates type 1 diabetes 
through regulating the function of  RyR2. Chen et al[80] 
demonstrated that the ATP-gated ion channel P2X7 was 
required for the acceleration of  type 1 diabetes induced 
by CD38 deficiency. Taken together, knowledge about 
the role of  the CD38/cADPR/Ca2+ pathway in diabetes 
is accumulating rapidly and there is hope that understand-
ing this pathway will facilitate the development of  novel 
therapeutics for the disease. 
The CD38/cADPR/Ca2+ pathway has been associat-
ed with inflammatory airway disorders. In human airway 
smooth muscle (ASM) cells, increased ASM contractil-
ity in inflammatory diseases such as asthma was due to 
enhanced Ca2+ sensitivity to cytokines, which was corre-
lated with the increase of  CD38 expression and cADPR 
level[81]. This increase of  CD38 was induced by TNFα 
via NFκB and could be inhibited by glucocorticoids[82]. 
In addition, the CD38/cADPR/Ca2+ pathway also me-
diated the 2-arachidonoylglycerol induced rapid actin 
rearrangement during differentiation of  HL-60 cells into 
macrophage-like cells[83], and extracellular NAD+ induced 
stimulation and recruitment of  human granulocytes dur-
ing the inflammation process[84]. In addition, CD38 was 
involved in a neuroinflammatory disorder where CD38 
expression level was markedly increased in IL-1beta- or 
HIV-1-activated human astrocytes, whereas CD38 knock-
down significantly reduced proinflammatory cytokine and 
chemokine production in astrocytes[85]. Considering these 
results, the CD38/cADPR/Ca2+ pathway plays important 
roles in multiple inflammatory processes.
CONCLUSION
The CD38/cADPR/Ca2+ pathway modulates various 
processes of  cells, including inflammation, insulin secre-
tion, cardiogenesis, cardiac regulation etc. With further 
investigation, it is likely that other physiological roles of  
the CD38/cADPR/Ca2+ pathway will be revealed. For 
example, Yue et al[64] have shown that the CD38/cAD-
PR/Ca2+ pathway delayed the nerve growth factor in-
duced differentiation of  PC12 cells; thus it is reasonable 
to predict that this pathway might also be involved in the 
regulation of  neurogenesis. Using the mouse embryonic 
stem cell in vitro differentiation model, our preliminary re-
sults showed that the CD38/cADPR/Ca2+ pathway does 
play a role in neural differentiation of  mES (unpublished 
data); however, further research is needed to decipher the 
underlying mechanism. A comprehensive understanding 
of  the physiological and pathological roles of  the CD38/
cADPR/Ca2+ pathway in various cellular processes will 
undoubtedly be helpful for exploiting new molecular 
therapy targets. In addition, it still remains to be deter-
mined whether cADPR binds directly to RyRs or through 
some unknown proteins. Recently, the long-sought-after 
store-operated Ca2+ entry proteins were identified using a 
genome-wide RNAi screen by several groups[86-88]. A simi-
lar strategy could be applied to identify novel cADPR-
interacting proteins or regulators.
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